Affordable Access

deepdyve-link
Publisher Website

A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation.

Authors
  • Lynch, Aisling M
  • Pathak, Nupur
  • Pathak, Varun
  • O'Harte, Finbarr P M
  • Flatt, Peter R
  • Irwin, Nigel
  • Gault, Victor A
Type
Published Article
Journal
Diabetologia
Publisher
Springer-Verlag
Publication Date
Sep 01, 2014
Volume
57
Issue
9
Pages
1927–1936
Identifiers
DOI: 10.1007/s00125-014-3296-7
PMID: 24962667
Source
Medline
License
Unknown

Abstract

This study emphasises the potential of (D-Ser(2))glucagon-exe for the treatment of obesity-related diabetes.

Report this publication

Statistics

Seen <100 times